More Medical News
Tranzyme GI drug fails second late-stage trial

(Reuters) - Tranzyme Pharma said its experimental drug to improve gastrointestinal recuperation after surgery failed to meet the main or secondary goals of a second late-stage trial. In March, the company said it would stop transformation of the drug, ul...

More: - Continued here

Share |
(Posted in Medical School)
Share and enjoy
  • Digg
  • DZone
  • Netvouz
  • NewsVine
  • Reddit
  • Slashdot
  • StumbleUpon
  • Technorati
  • YahooMyWeb
Entry 1 of 19080
Last Page | Next Page